EN DE
Watch Nano X Imaging Ltd for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Nano X Imaging Ltd (NNOX) fair value: what the stock is really worth

As of Nov 6, 2026: fair value (intrinsic value) of Nano X Imaging Ltd stock $0.56, price $0.24, upside +133.1%, quality 30 out of 100. Rating: strongly undervalued. Calculated from audited financials with one of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare US · Home Israel · ISIN IL0011681371

NX Nano X Imaging Ltd logo Thin data Nov 3, 2026

Nano X Imaging Ltd

NNOX · US
Cheap, value-trap risk

The stock costs 57% less than our calculation considers fair.

Fair value $0.5600 · Strongly undervalued
Low debt
Ranks above peers (5/8)
Revenue last quarter +37% vs. a year ago.
Mixed Growth (revenue 3y +14.9 %/yr in USD)
Insiders bought $190,656 (6M) · sold $1,119
Quality 30/100
Negative free cash flow
Narrow moat 8/100
Downbeat coverage
Thin data
Watch Nano X Imaging Ltd for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$30.12 $0.2402 Fair Value $0.5600 Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 3, 2026.

How to read this chart

60‑month range $0.2402 – $30.12 · fair‑value band $0.3700 – $0.7100 · the $0.2402 price screens below the $0.5600 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 3, 2026.

Follow Nano X Imaging in your weekly email

Every Wednesday you see whether Nano X Imaging is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications.

Show moreShow less

The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source; and Nanox.

CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting.

It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists; Nanox.CONNECT to receive local regulatory approvals and explore and evaluate the business model and the potential service; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data of existing computed tomography scans; and Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers and mobile imaging service providers, urgent care facilities, and multi-specialty physician groups.

In addition, the company provides Real+ Osteoporosis Care Management Platform, a osteoporosis care management software platform; AI-Based Aortic Valve Calcification Measurement, an artificial intelligence"based solution; AI-Based Body Composition Measurement, an artificial intelligence"based body composition analysis capability; and Nanox Health IT, a healthcare information technology services provider that serves hospitals and other healthcare organizations.

Nano-X Imaging Ltd. was founded in 2011 and is headquartered in Petah Tikva, Israel.

Stock analysis

Nano X Imaging Ltd (NNOX) currently trades at $0.2402, while our model-based Fair Value estimate is $0.5600, implying the stock looks roughly 57% undervalued today.

Show more

Valuation

How firm this estimate is: it rests on 1 models at a data quality of 96/100, which puts the data coverage at low.

Scenario range: $0.3700 (bear) to $0.7100 (bull), the price of $0.2402 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 30/100 (below-average quality), in the Healthcare sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Nano X Imaging Ltd reported revenue of $13.0M in FY2025 versus $1.3M in FY2021, a compound +77.8%/yr. Reported net income was −$75.0M in FY2025.

Key figures

Market cap $25.3M Micro · P/S ratio 1.62 · EPS (TTM) $−1.72 · Return on equity −99.0% · Return on assets (EBIT) −30.6% (5-year average) · Operating margin −355% · Revenue (TTM) $15.6M · Revenue growth (YoY) +36.7%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 8 out of 100 (medium confidence).

What moves the price

The share trades about 95% below its 52-week high and at its 52-week low.

For context, the median of 10 Healthcare peers we cover trades at −15% fair-value upside, at 133%, NNOX screens cheaper than that median.

Fair Value models

Bear $0.3700 Fair Value $0.5600 Bull $0.7100
Price $0.2402 · Upside +133.1%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
NCAV (Graham) $0.3700 $0.5600 $0.7100 54
All 1 models by family
Asset-Based
NCAV (Graham) $0.3700 $0.5600 $0.7100 54

Open the full fair value analysis →

Quality Score breakdown

Overall quality 30/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 0
How much profit the company makes from its sales and capital
Quality Growth 48
Are margins and returns getting better?
Cashflow 1
Do the profits arrive as real cash?
Financial strength 74
Debt, balance sheet and risk of trouble
Investment 67
Does it invest with discipline instead of growing at any price?
Low Volatility 21
How calm the share price moves, does not count
Price momentum 0
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 0
Distance to the 52-week high, does not count
New shares 2
Buys back shares or issues new ones?

Open the full quality analysis →

Insider trades

In the last 6 months, 3 officers or directors bought shares worth $190,656, most recently on Oct 19, 2026. Over the same period, one person sold shares worth $1,119. Buying cluster

  • BuyErez MeltzerChief Executive Officer, Director5× since Jul 27, 2026: 90,443 shares, avg. $0.7646$69,156Oct 19, 2026
  • BuyDan S SuesskindDirector2× since Jul 27, 2026: 110,000 shares, avg. $0.8345$91,800Sep 14, 2026
  • BuyNoga KainanDirector33,000 shares at $0.9000$29,700Jul 28, 2026
  • SaleErez AlroyDirector678 shares at $1.65$1,119Jun 10, 2026

Plus 8 other filings such as grants, option exercises or tax withholding. They are not market purchases or sales.

Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.

Source: SEC Form 4, as of Nov 6, 2026. All filings at the SEC ↗

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 26/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+15.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+14.9%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−4,720.7% (2021) → −466.2% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Watch NNOX, get fair value alerts →

Earlier news

News mood ⓘNews mood, the average tone of recent news (88 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation. Very negative
Recent news coverage is unusually downbeat.

Compare Nano X Imaging Ltd with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 318 stocks

Beats the industry median on 5/7 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 30 · Bottom 25%
Fair Value upside +133.1% · Top 25%
Profitability
Return on assets −46.3% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) 36.7% · Top 25%
Balance sheet
Debt / equity 0.03× · Below median

Valuation Multiplesvs Medical Devices median · lower = cheaper

P/B 0.18× · Cheapest 25%
P/S (12 months) 1.62× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)100 · sector 6
FUTURE (revenue growth)100 · sector 36
PAST (return on equity)0 · sector 17
HEALTH (low debt)99 · sector 98
DIVIDEND (yield)0 · sector 34

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Devices stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Stryker Corporation SYK $325.87 $358.46 +10% vs NNOX
Boston Scientific Corporation BSX $42.75 $47.03 +10% vs NNOX
Shenzhen Mindray Bio-Medical Electronics Co 300760 ¥184.15 ¥202.57 +10% vs NNOX
DexCom, Inc DXCM $79.41 $87.35 +10% vs NNOX
GE HealthCare Technologies Inc GEHC $82.38 $69.92 −15% vs NNOX
Edwards Lifesciences Corporation EW $102.14 $81.94 −20% vs NNOX
Siemens Healthineers AG SHL €44.66 €34.51 −23% vs NNOX
Abbott Laboratories, ABT $109.93 $75.28 −32% vs NNOX
Medtronic plc MDT $101.80 $65.61 −36% vs NNOX
Koninklijke Philips N.V PHIA €27.33 €15.23 −44% vs NNOX

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Nano X Imaging Ltd: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Nano X Imaging Ltd Fair Value". https://www.fairvalue-calculator.com/stock/NNOX

Frequently asked questions

Is Nano X Imaging Ltd (NNOX) overvalued or undervalued?
As of Nov 3, 2026, our model estimates a fair value of $0.5600 versus a price of $0.2402, about +133% upside (undervalued).
What is the fair value of NNOX?
Our model-based fair value for Nano X Imaging Ltd is $0.5600 (as of Nov 3, 2026), built from audited fundamentals. The current price: $0.2402.
What is the quality score of NNOX?
Nano X Imaging Ltd has a Quality Score of 30/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Nano X Imaging Ltd (NNOX)?
Our model-based price target is the fair value of $0.5600 (as of Nov 3, 2026) from 1 valuation models. Cautious scenario $0.3700, optimistic scenario $0.7100. It is a calculation from audited fundamentals, not an analyst target.
What is the Nano X Imaging Ltd stock forecast for 2026?
Our models put fair value at $0.5600, about +133% upside versus a price of $0.2402 (undervalued). Cautious scenario $0.3700, optimistic scenario $0.7100. The calculation is refreshed regularly with new filings.
What is the revenue of Nano X Imaging Ltd (NNOX)?
Nano X Imaging Ltd reported trailing-twelve-month revenue of about $15.6M (latest available figure, as of Nov 3, 2026).
What is the intrinsic value of Nano X Imaging Ltd (NNOX)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Nano X Imaging Ltd it is $0.5600 per share (as of Nov 3, 2026), against a price of $0.2402. It is the blended result of 1 valuation models in 1 family (Asset-Based).
Is Nano X Imaging Ltd stock overvalued or undervalued in 2026?
As of Nov 3, 2026, NNOX trades below its calculated fair value: price $0.2402, fair value $0.5600, a gap of about +133% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of NNOX?
No. The price is what the market pays today ($0.2402); the fair value is what the company's own numbers justify ($0.5600). For Nano X Imaging Ltd the two are $0.3198 per share apart. That gap is exactly why we show both numbers side by side.
How much is Nano X Imaging Ltd worth?
The market values Nano X Imaging Ltd at about $25.3M (market capitalisation, as of Nov 3, 2026). Per share that is $0.2402; our models calculate a fair value of $0.5600 per share.
What do the bullish and bearish scenarios say about NNOX?
Our models span a range for Nano X Imaging Ltd: cautious scenario $0.3700, base $0.5600, optimistic $0.7100 per share (as of Nov 3, 2026, price $0.2402). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Nano X Imaging Ltd (NNOX)?
Balance-sheet figures for Nano X Imaging Ltd (as of Nov 3, 2026): return on equity −99.0%, debt of 0.03 per unit of equity. They feed the Quality Score of 30/100, which measures business quality independently of the share price.
How far is NNOX from its 52-week high?
Nano X Imaging Ltd trades at $0.2402, about 95% below its 52-week high of $4.55 and at the low of $0.2402 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of $0.5600 is for.
Which stocks are comparable to Nano X Imaging Ltd?
From the same area (Healthcare) we also value Abbott Laboratories,, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Nano X Imaging Ltd stock attractive at the current price?
The data as of Nov 3, 2026: price $0.2402, calculated fair value $0.5600 (+133%), Quality Score 30/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of NNOX calculated?
We run Nano X Imaging Ltd through 1 models from 1 family: Asset-Based. Every model gets the same audited fundamentals; the fair value of $0.5600 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Nano X Imaging Ltd currently trades 57% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Nano X Imaging Ltd (NNOX)?
The closing price on Nov 6, 2026 was $0.2402. Our model-based fair value is $0.5600, about +133% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Nano X Imaging Ltd right now?
The large discount to fair value meets weak quality (30/100). That raises the risk this is a value trap rather than a bargain. The price is below even our cautious bear case ($0.3700). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range ($0.3700 to $0.7100) leaves room in how you read the outcome.

Key figures of Nano X Imaging Ltd

How large is the market capitalisation of Nano X Imaging Ltd (NNOX)?
The market capitalisation of Nano X Imaging Ltd is $25.3M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Nano X Imaging Ltd (NNOX)?
The price-to-sales ratio of Nano X Imaging Ltd is 1.62 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Nano X Imaging Ltd (NNOX)?
Earnings per share at Nano X Imaging Ltd are $−1.72. Earnings per share over the last twelve months: total profit spread across every single share.
What is the return on equity of Nano X Imaging Ltd (NNOX)?
The return on equity (ROE) of Nano X Imaging Ltd is −99.0% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Nano X Imaging Ltd (NNOX)?
On an EBIT basis the return on assets of Nano X Imaging Ltd is −30.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Nano X Imaging Ltd (NNOX)?
The operating margin of Nano X Imaging Ltd is −355% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Nano X Imaging Ltd (NNOX)?
Revenue at Nano X Imaging Ltd is growing +36.7% versus a year earlier (3y avg +14.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Nano X Imaging Ltd (NNOX) generate?
The free cash flow of Nano X Imaging Ltd is −$45.0M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Nano X Imaging Ltd (NNOX) hold?
Nano X Imaging Ltd holds more cash than debt, $41.3M net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Nano X Imaging Ltd in the live analysis

One click puts Nano X Imaging Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.